Home > Income Statement > VALIANT LABORATORIES

VALIANT LABORATORIES
Revenue

    Back to Income Statement
VALIANT LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Net Sales ₹237 Cr₹133 Cr₹182 Cr₹334 Cr

What is the latest Revenue of VALIANT LABORATORIES ?

The latest Revenue ratio of VALIANT LABORATORIES is ₹237 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹237 Cr
Mar2025₹133 Cr
Mar2024₹182 Cr
Mar2023₹334 Cr

How is Revenue of VALIANT LABORATORIES Trending?

Years Revenue % Change
Mar2026 ₹237 Cr
78.04
Mar2025 ₹133 Cr
-26.74
Mar2024 ₹182 Cr
-45.48
Mar2023 ₹334 Cr -

Compare Revenue of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹538.7 Cr -7.7% -29.7% 26.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,299.0 Cr 1% 7.5% 7.9% Stock Analytics
DIVIS LABORATORIES ₹297,325.0 Cr 0.8% 22.8% 71.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹178,727.0 Cr 0.2% 1.9% 20.9% Stock Analytics
DR REDDYS LABORATORIES ₹116,145.0 Cr 0.8% 12.2% 12.3% Stock Analytics
CIPLA ₹114,312.0 Cr 1.5% 6.4% -7.8% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-7.7%

-29.7%

26.5%

SENSEX

2.9%

13.9%

-0.8%


You may also like the below Video Courses